Concepedia

Publication | Open Access

A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma

45

Citations

8

References

1995

Year

Abstract

Octreotide at a dose of 150 micrograms given three times daily is not effective therapy for patients with advanced asymptomatic colon carcinoma.

References

YearCitations

1988

483

1994

330

1987

191

1982

130

1988

128

1985

103

1994

87

1983

44

Page 1